Johnson & Johnson K.K. Medical Company
8
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
13%
1 trials in Phase 3/4
50%
4 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
DSJ-2016-07 ATTUNE® Cementless CR RP Japan
Role: collaborator
Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively
Role: collaborator
Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses
Role: collaborator
Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)
Role: lead
Follow-up Study After Bankart Repair Using MG-1
Role: lead
A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery Disease
Role: lead
Open-Label Study for Shoulder Dislocation Using MG-1
Role: lead
Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic Tests
Role: collaborator
All 8 trials loaded